The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries.Expanded collaboration…
Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…
COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne…
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…